High-affinity interaction between IKKβ and NEMO

Biochemistry

Volumn 47, Issue 10, 2008, Pages 3109-3116

  Lo, Yu Chih ^a   Maddineni, Upendra ^a,b   Chung, Jee Y ^a,d   Rich, Rebecca L ^c   Myszka, David G ^c   Wu, Hao ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Tri Institutional MD PHD Program   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; BIOCHEMICAL ENGINEERING; ENZYME ACTIVITY; REFRACTIVE INDEX; SURFACE PLASMON RESONANCE;

BINDING DOMAIN; MULTIANGLE LIGHT SCATTERING (MALS);

PROTEINS;

I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA;

ARTICLE; BINDING AFFINITY; HUMAN; ISOTHERMAL TITRATION CALORIMETRY; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REFRACTION INDEX; STOICHIOMETRY; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

AMINO ACID SEQUENCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; I-KAPPA B KINASE; KINETICS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE; THERMODYNAMICS;

EID: 40549103434     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702312c     Document Type: Article

References (54)

1. Greten, F. R., and Karin, M. (2004) The IKK/NF-κB activation pathway: A target for prevention and treatment of cancer. Cancer Lett. 206, 193-199.
2. Hayden, M. S., and Ghosh, S. (2004) Signaling to NF-κB. Genes Dev. 18, 2195-2224.
3. Gilmore, T. D. (2006) Introduction to NF-κB: Players, pathways, perspectives. Oncogene 25, 6680-6684.
4. Scheidereit, C. (2006) IκB kinase complexes: Gateways to NF-κB activation and transcription. Oncogene 25, 6685-6705.
5. Chen, Z. J. (2005) Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765.
6. Ardley, H. C., and Robinson, P. A. (2005) E3 ubiquitin ligases. Essays Biochem. 41, 15-30.
7. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z. J. (2000) Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361.
8. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J., and Chen, Z. J. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351.
9. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K. (1999) The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256.
10. Holtmann, H., Enninga, J., Kalble, S., Thiefes, A., Dorrie, A., Broemer, M., Winzen, R., Wilhelm, A., Ninomiya-Tsuji, J., Matsumoto, K., Resch, K., and Kracht, M. (2001) The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J. Biol. Chem. 276, 3508-3516.
11. Irie, T., Muta, T., and Takeshige, K. (2000) TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 467, 160-164.
12. Lee, J., Mira-Arbibe, L., and Ulevitch, R. J. (2000) TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukocyte Biol. 68, 909-915.
13. Jiang, Z., Zamanian-Daryoush, M., Nie, H., Silva, A. M., Williams, B. R., and Li, X. (2003) Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFκB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278, 16713-16719.
14. Mizukami, J., Takaesu, G., Akatsuka, H., Sakurai, H., Ninomiya-Tsuji, J., Matsumoto, K., and Sakurai, N. (2002) Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22, 992-1000.
15. Besse, A., Lamothe, B., Campos, A. D., Webster, W. K., Maddineni, U., Lin, S. C., Wu, H., and Darnay, B. G. (2007) TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J. Biol. Chem. 282, 3918-3928.
16. Lamothe, B., Besse, A., Campos, A. D., Webster, W. K., Wu, H., and Darnay, B. G. (2007) Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102-4112.
17. Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J., Young, D. B., Barbosa, M., Mann, M., Manning, A., and Rao, A. (1997) IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
18. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., and Karin, M. (1997) The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243-252.
19. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
20. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M., and Goeddel, D. V. (1997) IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278, 866-869.
21. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., and Israel, A. (1998) Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240.
22. Rothwarf, D. M., Zandi, E., Natoli, G., and Karin, M. (1998) IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395, 297-300.
23. Mercurio, F., Murray, B. W., Shevchenko, A., Bennett, B. L., Young, D. B., Li, J. W., Pascual, G., Motiwala, A., Zhu, H., Mann, M., and Manning, A. M. (1999) IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19, 1526-1538.
24. Poyet, J. L., Srinivasula, S. M., Lin, J. H., Fernandes-Alnemri, T., Yamaoka, S., Tsichlis, P. N., and Alnemri, E. S. (2000) Activation of the IκB kinases by RIP via IKKγ/NEMO-mediated oligomerization. J. Biol. Chem. 275, 37966-37977.
25. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. (1999) Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284, 309-313.
26. May, M. J., D'Acquisto, F., Madge, L. A., Glockner, J., Pober, J. S., and Ghosh, S. (2000) Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289, 1550-1554.
27. Tegethoff, S., Behlke, J., and Scheidereit, C. (2003) Tetrameric oligomerization of IκB kinase γ (IKKγ) is obligatory for IKK complex activity and NF-κB activation. Mol. Cell. Biol. 23, 2029-2041.
28. Biswas, D. K., Shi, Q., Baily, S., Strickland, I., Ghosh, S., Pardee, A. B., and Iglehart, J. D. (2004) NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 101, 10137-10142.
29. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F., and Karin, M. (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296.
30. Davis, R. E., Brown, K. D., Siebenlist, U., and Staudt, L. M. (2001) Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194, 1861-1874.
31. Zhou, Y., Eppenberger-Castori, S., Marx, C., Yau, C., Scott, G. K., Eppenberger, U., and Benz, C. C. (2005) Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers. Int. J. Biochem. Cell Biol. 37, 1130-1144.
32. Andresen, L., Jorgensen, V. L., Perner, A., Hansen, A., Eugen-Olsen, J., and Rask-Madsen, J. (2005) Activation of nuclear factor κB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54, 503-509.
33. Shukla, S., Maclennan, G. T., Marengo, S. R., Resnick, M. I., and Gupta, S. (2005) Constitutive activation of PI3K-Akt and NF-κB during prostate cancer progression in autochthonous transgenic mouse model. Prostate YY, 224-239.
34. Krappmann, D., Emmerich, F., Kordes, U., Scharschmidt, E., Dorken, B., and Scheidereit, C. (1999) Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18, 943-953.
35. Aupperle, K., Bennett, B., Han, Z., Boyle, D., Manning, A., and Firestein, G. (2001) NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J. Immunol. 166, 2705-2711.
36. Ludwig, L., Kessler, H., Wagner, M., Hoang-Vu, C., Dralle, H., Adler, G., Bohm, B. O., and Schmid, R. M. (2001) Nuclear factor-κB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res. 61, 4526-4535.
37. Tamatani, T., Azuma, M., Aota, K., Yamashita, T., Bando, T., and Sato, M. (2001) Enhanced IκB kinase activity is responsible for the augmented activity of NF-κB in human head and neck carcinoma cells. Cancer Lett. 171, 165-172.
38. Karin, M., Yamamoto, Y., and Wang, Q. M. (2004) The IKK NF-κB system: A treasure trove for drug development. Nat. Rev. Drug Discovery 3, 17-26.
39. Burke, J. R. (2003) Targeting IκB kinase for the treatment of inflammatory and other disorders. Curr. Opin. Drug Discovery Dev. 6, 720-728.
40. Yang, J., and Richmond, A. (2001) Constitutive IκB kinase activity correlates with nuclear factor-κB activation in human melanoma cells. Cancer Res. 61, 4901-4909.
41. Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., Adams, J., and Anderson, K. C. (2002) NF-κB as a therapeutic target in multiple myeloma. J. Biol. Chem. 277, 16639-16647.
42. Jin, S. H., Kim, T. I., Han, D. S., Shin, S. K., and Kim, W. H. (2002) Thalidomide suppresses the interleukin 1β-induced NFκB signaling pathway in colon cancer cells. Ann. N. Y. Acad. Sci. 973, 414-418.
43. Choi, M., Rolle, S., Wellner, M., Cardoso, M. C., Scheidereit, C., Luft, F. C., and Kettritz, R. (2003) Inhibition of NF-κB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 102, 2259-2267.
44. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., Okabe, K., Ohya, K., and Ghosh, S. (2004) Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617-624.
45. Myszka, D. G. (1999) Improving biosensor analysis. J. Mol. Recognit. 12, 279-284.
46. May, M. J., Marienfeld, R. B., and Ghosh, S. (2002) Characterization of the IκB-kinase NEMO binding domain. J. Biol. Chem. 277, 45992-46000.
47. Tas, S. W., de Jong, E. C., Hajji, N., May, M. J., Ghosh, S., Vervoordeldonk, M. J., and Tak, P. P. (2005) Selective inhibition of NF-κB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization. Eur. J. Immunol. YY, 1164-1174.
48. Rehman, K. K., Bertera, S., Bottino, R., Balamurugan, A. N., Mai, J. C., Mi, Z., Trucco, M., and Robbins, P. D. (2003) Protection of islets by in situ peptide-mediated transduction of the IκB kinase inhibitor Nemo-binding domain peptide. J. Biol. Chem. 278, 9862-9868.
49. Dai, S., Hirayama, T., Abbas, S., and Abu-Amer, Y. (2004) The IκB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J. Biol. Chem. 279, 37219-37222.
50. Rost, B., Yachdav, G., and Liu, J. (2004) The PredictProtein server. Nucleic Acids Res. 32, W321-W326.
51. Wolf, E., Kim, P. S., and Berger, B. (1997) MultiCoil: A program for predicting two- and three-stranded coiled coils. Protein Sci. 6, 1179-1189.
52. Agou, F., Courtois, G., Chiaravalli, J., Baleux, F., Coic, Y. M., Traincard, F., Israel, A., and Veron, M. (2004) Inhibition of NF-κB activation by peptides targeting NF-κB essential modulator (nemo) oligomerization. J. Biol. Chem. 279, 54248-54257.
53. Wu, H., Myszka, D. G., Tendian, S. W., Brouillette, C. G., Sweet, R. W., Chaiken, I. M., and Hendrickson, H. A. (1996) Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. Proc. Natl. Acad. Sci. U.S.A. 93, 15030-15035.
54. Chesnokova, L. S., Slepenkov, S. V., Protasevich, I. I., Sehorn, M. G., Brouillette, C. G., and Witt, S. N. (2003) Deletion of DnaK's lid strengthens binding to the nucleotide exchange factor, GrpE: A kinetic and thermodynamic analysis. Biochemistry 42, 9028-9040.